Clinical Trials Directory

Trials / Unknown

UnknownNCT01344694

Epicardial Fat, Visceral Fat and Coronary Atherosclerosis

Association Between Epicardial Fat, Visceral Fat Accumulation & Cardiovascular Atherosclerosis

Status
Unknown
Phase
Study type
Observational
Enrollment
110 (estimated)
Sponsor
Ziv Hospital · Other Government
Sex
All
Age
40 Years – 70 Years
Healthy volunteers
Accepted

Summary

Background: Visceral fat is increasingly associated with metabolic syndrome and with fatty liver, a condition carrying a high risk of cardiovascular disease. The independent role of epicardial fat deposition in cardiovascular risk remains unclear.

Detailed description

Background: Visceral fat is increasingly associated with metabolic syndrome and with fatty liver, a condition carrying a high risk of cardiovascular disease. The independent role of epicardial fat deposition in cardiovascular risk remains unclear. Aim: Evaluate the link between epicardial fat, visceral fat, liver fat accumulation and cardiovascular diseases and carotis atherosclerosis in patients with the major cardiovascular risk factors and with or without metabolic syndrome.

Conditions

Interventions

TypeNameDescription
OTHERpatient with liver fat30 patient with liver fat
OTHERpts. with excess of visceral fatpts. with excess of visceral fat
OTHERcontrol30 control subjects

Timeline

Start date
2011-07-01
Primary completion
2012-02-01
Completion
2012-03-01
First posted
2011-04-29
Last updated
2011-05-16

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT01344694. Inclusion in this directory is not an endorsement.

Epicardial Fat, Visceral Fat and Coronary Atherosclerosis (NCT01344694) · Clinical Trials Directory